Anti-Xa Directed Thromboprophylaxis in Critically Ill Patients with Coronavirus Disease 2019

Objective: To compare Anti-Xa directed thromboprophylaxis using low molecular weight heparin (LMWH) (anti-Xa peak goal 0.2-0.5 IU/mL) to alternative anticoagulation strategies in critically ill COVID-19 patients. Methods: This was a retrospective, multicenter, single health-system study. Primary out...

Descripción completa

Detalles Bibliográficos
Autores principales: Mohamed, Adham, Shemanski, Shelby M, Saad, Mohamed O, Ploetz, Jeannette, Haines, Michelle M, Schlachter, Andrew B, Hamarshi, Majdi S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Original Manuscript
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9358597/
https://www.ncbi.nlm.nih.gov/pubmed/35924413
http://dx.doi.org/10.1177/10760296221116350

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9358597/
https://www.ncbi.nlm.nih.gov/pubmed/35924413
http://dx.doi.org/10.1177/10760296221116350

Ejemplares similares